MSPR

SEC source: 0000950170-24-137245 · ownership.xml · derivative · entry 2

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,322,531

Underlying: Class A Common Stock · 1,012,123 shares

Expires not disclosed

F3 · security: Represents LLC units ("LLC Units") of Lionheart II Holdings, LLC ("Opco"), which are ach paired with one share of Class V Common Stock, par value $0.0001 per share, of the Issuer ("Class V Common Stock"). Each share of Class V Common Stock has the same voting rights as a share of Class A common stock, par value $0.0001 per share, of the Issuer ("Class A Common Stock"), but no economic rights. Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in: (i) Ruiz Group Holdings Limited, LLC, which beneficially owned 692,123 Up-C Units, and (ii) 320,000 Up-C Units held by Jocral Family LLLP.

F4 · price: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F4 · derivative.exercise_date: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F4 · derivative.expiration_date: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F5 · ownership.nature: Represents shares of Class A Common Stock issuable in respect of an equal number of Class B units (the "LLC Units") of Lionheart II Holdings, LLC, a wholly owned subsidiary of the Issuer ("Opco"), and shares of Class V common stock, par value $0.0001 per share ("Class V Common Stock," and together with an LLC Unit, an "Up-C Unit"), subject to the terms of the First Amended and Restated Limited Liability Company Agreement of Lionheart II Holdings, LLC (the "LLC Agreement"), held as follows: (a) 463,096 by Series MRCS, a series of MDA, Series LLC ("Series MRCS") (including 80,271 held on behalf of Jocral Holdings LLC); and (b) 1,859,435 by Jocral Family LLLP.

SEC source: 0000950170-24-137245 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 111,657

F1 · shares: Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in Ruiz Group Holdings Limited, LLC to his ex-wife, Mayra Ruiz, which beneficially owned 16,000 shares of Class A Common Stock.

F1 · price: Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in Ruiz Group Holdings Limited, LLC to his ex-wife, Mayra Ruiz, which beneficially owned 16,000 shares of Class A Common Stock.

F2 · ownership.nature: Represents: (a) 40,000 shares of Class A Common Stock held by Jocral Family LLLP; and (b) 71,657 shares of Class A Common Stock held John H. Ruiz, individually.

SEC source: 0000950170-24-137403 · ownership.xml · derivative · entry 2

Ruiz Mayra Cristina · CIK 0001930306 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,012,132

Underlying: Class A Common Stock · 1,012,123 shares

Expires not disclosed

F4 · security: Represents shares of Class A Common Stock issuable in respect of an equal number of Class B units (the "LLC Units") of Lionheart II Holdings,LLC, a wholly owned subsidiary of the Issuer ("Opco"), and shares of Class V common stock, par value $0.0001 per share ("Class V Common Stock," and together with an LLC Unit, an "Up-C Unit"), subject to the terms of the First Amended and Restated Limited Liability CompanyAgreement of Lionheart II Holdings, LLC (the "LLC Agreement"). Effective December 13, 2024, pursuant to a marital settlement agreement, Mayra C. Ruiz acquired from John H. Ruiz: (i) Ruiz Group Holdings Limited, LLC, which holds 692,123 Up-C Units; and (ii) 320,000 Up-C Units held by Jocral Family LLLP.

F5 · derivative.exercise_price: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F5 · price: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F5 · derivative.exercise_date: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F5 · derivative.expiration_date: Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

F6 · ownership.nature: Represents Up-C Units held as follows: (a) 692,123 Up-C Units by Ruiz Group Holdings Limited, LLC; and (b) 320,000 Up-C Units held by Mayra C. Ruiz, individually.

SEC source: 0000950170-24-137403 · ownership.xml · nonDerivative · entry 1

Ruiz Mayra Cristina · CIK 0001930306 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 16,000

F1 · shares: Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in Ruiz Group Holdings Limited, LLC to his ex-wife, Mayra C. Ruiz, which beneficially owned 16,000 shares of Class A Common Stock.

F2 · balance_after: Includes 16,000 shares of Class A Common Stock held by Ruiz Group Holdings Limited, LLC.

F3 · ownership.nature: Represents 16,000 shares of Class A Common Stock held by Ruiz Group Holdings Limited, LLC.

SEC source: 0001321655-24-000211 · wk-form4_1730943130.xml · nonDerivative · entry 3

Palantir Technologies Inc. · CIK 0001321655 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,985,381

F3 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.1035 to $0.1638. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001321655-24-000211 · wk-form4_1730943130.xml · nonDerivative · entry 2

Palantir Technologies Inc. · CIK 0001321655 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,491,677

F2 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.10 to $0.1185. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001321655-24-000211 · wk-form4_1730943130.xml · nonDerivative · entry 1

Palantir Technologies Inc. · CIK 0001321655 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,831,977

F1 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.097 to $0.1055. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001321655-24-000203 · wk-form4_1730505779.xml · nonDerivative · entry 3

Palantir Technologies Inc. · CIK 0001321655 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,943,737

F3 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.092 to $0.1129. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001321655-24-000203 · wk-form4_1730505779.xml · nonDerivative · entry 2

Palantir Technologies Inc. · CIK 0001321655 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,280,911

F2 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.098 to $0.1352. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001321655-24-000203 · wk-form4_1730505779.xml · nonDerivative · entry 1

Palantir Technologies Inc. · CIK 0001321655 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,662,398

F1 · price: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.1195 to $0.1287. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0000950170-24-101382 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,791,406

SEC source: 0000950170-24-099702 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,741,406

SEC source: 0000950170-24-099485 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,380,786

SEC source: 0000950170-24-099094 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,280,786

SEC source: 0000950170-24-098498 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,180,786

SEC source: 0000950170-24-098069 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,080,786

SEC source: 0000950172-24-000170 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 903,655

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.72 to $1.035. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000170 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,013,155

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6642 to $0.6789. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000153 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,043,531

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.683 to $0.701. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000153 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,069,309

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.7344. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000098 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,094,244

F4 · price: 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7222 to $0.735. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000098 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,114,244

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000098 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,137,844

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.74 to $0.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000090 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,190,346

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.771. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000090 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,234,057

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.775. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000090 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,280,303

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.795. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000065 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,308,360

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.78 to $0.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000065 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,350,297

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000065 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,394,602

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000046 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,455,347

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.83 to $0.8675. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000046 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,496,931

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.88 to $0.9395. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950172-24-000046 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,549,190

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.93 to $0.9902. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001096906-24-000372 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,586,154

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.95 to $1.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001096906-24-000372 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,608,848

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.93 to $1.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001096906-24-000372 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,844,395

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.98 to $1.11. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001096906-24-000329 · form4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,977,913

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0000950170-24-024982 · ownership.xml · nonDerivative · entry 1

Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 912,786

F1 · security: The securities identified in Box 4 were purchased pursuant to a Stock Transfer Agreement dated March 4, 2024 by and between the Reporting Person and Virage Capital Managment LP ("Seller"). Payment by Reporting Person for the above-reference securities is due to Seller no later than May 1, 2024.

SEC source: 0001096906-24-000329 · form4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 3,338,727

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001096906-24-000329 · form4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,113,127

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $1.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-004121 · doc4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,645,818

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.862. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-004121 · doc4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,691,365

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.825. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-004121 · doc4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,728,206

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8043 to $0.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003978 · doc4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,740,206

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8019 to $0.8288. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003978 · doc4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,762,870

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003978 · doc4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,790,806

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.845. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003703 · doc4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,822,464

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.855. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003703 · doc4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,845,579

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003703 · doc4.xml · nonDerivative · entry 1

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,963,828

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.835. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003420 · doc4.xml · nonDerivative · entry 3

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,047,716

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

SEC source: 0001209191-24-003420 · doc4.xml · nonDerivative · entry 2

Cano Health, Inc. · CIK 0001800682 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,106,721

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.8099. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.